SOHM, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHMN research report →
Price Chart
About the company
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products.
- CEO
- Baron Night
- IPO
- 2010
- Employees
- 11
- HQ
- Corona, CA, US
Get TickerSpark's AI analysis on SHMN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.32M
- P/E
- 8.40
- PEG
- 0.02
- P/S
- 1.45
- P/B
- 0.71
- EV/EBITDA
- -18.35
- Div Yield
- 0.00%
- Gross Margin
- 78.12%
- Op Margin
- -27.25%
- Net Margin
- -28.08%
- ROE
- -8.05%
- ROIC
- -3.71%
Latest fiscal year · YoY change
- Revenue
- $1.18M+24.2%
- Gross Profit
- $878.61K+30.6%
- Op Income
- $-505,036
- Net Income
- $-506,484+16.7%
- EPS
- $0.00+100.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.77
- RSI (14)
- 47
- Avg Volume
- 579.16K
No earnings-call transcripts are available for SHMN yet.
- Free Float
- 0.0%
- Shares Outstanding
- 1.58B
- Float Shares
- 0
Our SHMN coverage
Recent articles, reports, and earnings notes.
No research on SHMN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SHMN report →SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery
accessnewswire.com · Nov 6
SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development
accessnewswire.com · Nov 4
SOHM, Inc., Moving and Expanding Commercialization Capabilities with its New Vista, CA Facility
accessnewswire.com · Sep 2
SOHM Achieves Breakthrough with ABBIE Gene Editing Platform, Advancing Strategic Partnership and Licensing Opportunities
accessnewswire.com · Aug 26
SOHM, Inc. Launches New User-Friendly Website to Enhance Customer, Investor Experience and Engagement
accessnewswire.com · Jul 21
SOHM, Inc. Appoints Ravi Kapoor as an Independent Director
accessnewswire.com · Jun 30
SOHM, Inc. Sets Strategic Goals to Enter Biotechnology-Driven Cosmeceuticals Market
accessnewswire.com · Jun 24
SOHM Inc. Welcomes Dr. Larissa Karnaoukhova as New Vice President of Operations
accessnewswire.com · Jun 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.